Total Investment Management’s Imunon IMNN Stock Holding History

Total Investment Management’s Portfolio IMNN Stock Details IMNN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-123	Closed	-$89K	–	49
2020 Q2	$89K	Buy	+123	New	+$53.3K	0.03%	43

Other funds holding IMNN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Total Investment Management's IMNN Position: Q3 2020 in Review

Total Investment Management sold out of Imunon (IMNN) in Q3 2020, closing a stake of 123 shares — an estimated $89K sold.

Total Investment Management first reported a position in IMNN in Q2 2020 and held it in 1 quarter. The position peaked at $89K in Q2 2020. 34 funds tracked by Wall St. Rank hold IMNN as of Q3 2020.

Total Investment Management reported no remaining Imunon position as of Q3 2020 after selling out during the quarter.
Total Investment Management sold 123 Imunon shares in Q3 2020, an estimated $89K.
Total Investment Management first reported a position in Imunon in Q2 2020 and held it in 1 quarter.
Total Investment Management's Imunon position peaked at $89K in Q2 2020.
34 funds tracked by Wall St. Rank held Imunon as of Q3 2020.

Based on Total Investment Management's 13F filing for Q3 2020, filed 2 Nov 2020.